Advances in Atopic Dermatitis Treatment: From Pathogenesis to Natural Product‐Based Therapies
Phytotherapy Research · 2025-10 · 39 (10) · 4444-4473
DOI: 10.1002/ptr.70056 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Phytotherapy Research, online erschienen am 19.08.2025. Verfasst von Xinyun Fan und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Biological Products. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Sichuan Provincial Administration of Traditional Chinese Medicine, Xinglin Scholars of Chengdu University of Traditional Chinese Medicine, Sichuan Science and Technology Program.
Abstract (Originalsprache)
Atopic dermatitis (AD), a widespread and chronic inflammatory skin disorder, profoundly affects patients' quality of life, imposes significant psychological strain, and adds to the public health burden. Recent studies have shown that AD is characterized by complex interactions between multiple signaling pathways and targets, including allergies, inflammation, oxidative stress, apoptosis, and their interactions. This complex pathogenesis poses challenges for effective treatment but also contributes to the discovery of new therapeutic targets and the development of novel therapeutic drugs, which have important clinical significance. This review delves into the pathogenesis of AD in recent years and explores the therapeutic potential of alkaloids, phenols, flavonoids, terpenes, glycosides, and other natural products (NPs). Specifically, it explores how NPs correct immune cell subpopulation imbalance, regulate keratinocyte function, and reduce mast cell activation and cytokine secretion. These therapeutic effects are promoted by regulating pathways such as NF‐κB, IgE‐FcεRI, MAPK, and JAK/STAT. Future research should design new compounds with therapeutic potential based on the structure of NPs and focus on pharmacological experiments and clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China.
- State Key Laboratory of Southwestern Chinese Medicine Resources, Innovative Institute of Chinese Medicine and Pharmacy/Academy for Interdiscioline, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China.
ORCID-Profile: Liang Li
Förderung
- Sichuan Provincial Administration of Traditional Chinese Medicine
- Xinglin Scholars of Chengdu University of Traditional Chinese Medicine
- Sichuan Science and Technology Program
Zitieren
APA
Fan, X., Liu, Z., Yang, W., Zhang, H., Zhong, H., Pang, Y., Ye, X., Wu, C., & Li, L. (2025). Advances in Atopic Dermatitis Treatment: From Pathogenesis to Natural Product‐Based Therapies. Phytotherapy Research, 39(10), 4444-4473. https://doi.org/10.1002/ptr.70056
Vancouver
Fan X, Liu Z, Yang W, Zhang H, Zhong H, Pang Y, et al. Advances in Atopic Dermatitis Treatment: From Pathogenesis to Natural Product‐Based Therapies. Phytotherapy Research. 2025;39(10):4444-4473. doi:10.1002/ptr.70056
BibTeX
@article{Fan2025,
author = {Fan, Xinyun and Liu, Zibo and Yang, Wenjing and Zhang, Hongying and Zhong, Hao and Pang, Yan and Ye, Xun and Wu, Chunjie and Li, Liang},
title = {Advances in Atopic Dermatitis Treatment: From Pathogenesis to Natural Product‐Based Therapies},
journal = {Phytotherapy Research},
year = {2025},
volume = {39},
number = {10},
pages = {4444--4473},
doi = {10.1002/ptr.70056}
}
EUVIMED